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Abstract
Background: Mycoplasmas are the simplest bacteria capable of autonomous replication. Their evolution
proceeded from gram-positive bacteria, with the loss of many biosynthetic pathways and of the cell wall. In this
work, the liposoluble protein complement of Mycoplasma agalactiae, a minimal bacterial pathogen causing
mastitis, polyarthritis, keratoconjunctivitis, and abortion in small ruminants, was subjected to systematic
characterization in order to gain insights into its membrane proteome composition.
Results: The selective enrichment for M. agalactiae PG2T liposoluble proteins was accomplished by means of Triton
X-114 fractionation. Liposoluble proteins were subjected to 2-D PAGE-MS, leading to the identification of 40 unique
proteins and to the generation of a reference 2D map of the M. agalactiae liposoluble proteome. Liposoluble
proteins from the type strain PG2 and two field isolates were then compared by means of 2D DIGE, revealing
reproducible differences in protein expression among isolates. An in-depth analysis was then performed by GeLC-
MS/MS in order to achieve a higher coverage of the liposoluble proteome. Using this approach, a total of 194
unique proteins were identified, corresponding to 26% of all M. agalactiae PG2T genes. A gene ontology analysis
and classification for localization and function was also carried out on all protein identifications. Interestingly, the
11.5% of expressed membrane proteins derived from putative horizontal gene transfer events.
Conclusions: This study led to the in-depth systematic characterization of the M. agalactiae liposoluble protein
component, providing useful insights into its membrane organization.
Background
Mycoplasmas are the smallest and simplest prokaryotes
capable of self-replication, being provided only with the
minimal machinery required for survival. During evolu-
tion, they have regressively evolved from gram-positive
bacteria by reduction of their genome to an essential
minimum, economizing their structural elements, meta-
bolic pathways, and genetic resources [1].
Among other consequences, this cost-cutting strategy
led to loss of the cell-wall component, and therefore to
lack of a peptidoglycan “shell”. Instead, sterols are incor-
porated into the lipid bilayer, providing resistance to
rupture, but still allowing a certain flexibility of cell
shape. Integral and associated membrane proteins are
therefore directly exposed and act as the immediate bac-
terial interface, playing a major role in survival and
pathogenesis [2,3]. Gathering information on membrane
proteins of such a pathogen might provide novel and
interesting insights on its biology, and generate useful
information for improving diagnosis, vaccination, and
therapy. Recently, a large-scale study was carried out on
the proteome of the human pathogen Mycoplasma
penetrans, based on the TAP-MS approach [4]. How-
ever, membrane proteins were not included in this
study, since they require dedicated protocols for purifi-
cation and analysis and present numerous challenges.
Many members of the genus Mycoplasma are patho-
genic for humans, animals, plants, and insects. M. agalac-
tiae is the etiological agent of Contagious Agalactia (CA),
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a serious disease of sheep and goats characterized by mas-
titis, polyarthritis, keratoconjunctivitis, and abortion
[1,5,6]. CA has a worldwide distribution and is endemic in
Mediterranean Countries [7], causing severe economic
losses in areas where economy is largely based on small
ruminant milk production [5].
In Europe, the disease has been tentatively controlled
either by vaccination or with serological tools based on
recombinant surface proteins [8-13]. At present, the two
above mentioned strategies are not actually compatible
until proper DIVA (Differentiating Infected from Vacci-
nated Animals) vaccines will allow discrimination of vacci-
nated animals from naturally infected ones. The highly
immunogenic, surface-associated membrane proteins
represent key antigens for diagnosis and vaccine develop-
ment. However, the finding of constantly expressed
surface proteins in mycoplasmas is complicated by the
existence of mechanisms aimed to evade the host immune
response [1,14-17]. Surface-associated proteins are also
pivotal for pathogenesis by acting as cytoadhesins [18]. To
date, a limited number of constantly expressed surface
proteins have been described in M. agalactiae. Among
them, P30, P48, and P80 were described as antigens
[19-21]; other proteins belong to the variable surface
membrane proteins family (Vpma) [14,17], and P40 was
suggested to play an important role in attachment to the
host cell [18].
Genetic approaches traditionally used for large scale
investigation of protein sets have been poorly applied to
mycoplasmas. The expression of immunogenic Myco-
plasma proteins in Escherichia coli expression libraries is
hampered by the very high A+T content (almost 80%)
and by the Mycoplasma-specific codon usage, resulting
in abnormal internal transcription/translation and in
premature termination, respectively [22,23]. In 2007, the
full genome sequence of the M. agalactiae type strain
PG2 (PG2T) was published [24] and paved the way for
systematic proteomic studies in mycoplasmas.
The combination of 2-D PAGE and mass spectrometry
(MS) is a well-established method for the systematic and
comparative study of proteomes, since it allows the
simultaneous visualization and identification of the pro-
tein complement of a cell. However, it is commonly
reported that standard 2-D PAGE lacks in resolution of
very hydrophobic and basic proteins, which are particu-
larly abundant in the Mycoplasma membrane [25-27].
Indeed, membrane proteins are poorly detected in 2-D
PAGE maps of Mycoplasma total protein extracts
[22,28]. Triton X-114 fractionation may assist in solving
this problem, since it was demonstrated to enable a selec-
tive enrichment in hydrophobic proteins [29,30]. Triton
X-114 fractionation followed by 2-D PAGE remains the
method of choice for proteomic characterization of the
membrane protein subset [31], and for differential analy-
sis of membrane protein expression among bacterial
strains [32]. More specifically, the recently developed Dif-
ferential In Gel Electrophoresis (DIGE) [33-35], based on
labeling of protein samples with fluorescent dyes before
2-D electrophoresis, enables the accurate analysis of dif-
ferences in protein abundance between samples. How-
ever, considering the above mentioned intrinsic
limitations of 2-D PAGE, other gel-based proteomic
approaches, such as one-dimensional PAGE and Liquid
Chromatography-Tandem Mass Spectrometry (GeLC-
MS/MS) [36], can be combined with the 2-D PAGE/MS
in order to mine deeper into a liposoluble proteome.
In this study, the membrane proteome of M. agalac-
tiae was characterized by means of Triton X-114 fractio-
nation, 2-D PAGE-MS, GeLC-MS/MS, and Gene
Ontology classification. Differential expression of mem-
brane proteins among M. agalactiae strains was also
evaluated by 2D DIGE.
Results
Extraction of bacterial proteins and isolation of
liposoluble proteins
This study was aimed to the systematic characterization
of M. agalactiae PG2T membrane proteins by means of
a gel-based proteomic approach. In order to increase
coverage for liposoluble proteins, a commercial fractio-
nation method and the classical Triton X-114 fractiona-
tion protocol were applied to M. agalactiae PG2T cell
lysates. The best results were obtained by means of Tri-
ton X-114 fractionation. Figure 1A illustrates the hydro-
soluble and liposoluble fractions obtained from
M. agalactiae PG2T, flanked by the total protein pattern
for comparison. The efficiency of the procedure in
separating liposoluble proteins was evaluated by Wes-
tern immunoblotting using a rabbit hyperimmune
serum raised against M. agalactiae P48, a previously
characterized surface lipoprotein [12,19]. As expected,
presence of P48 was observed only in the total extract
and in the Triton X-114 phase (Figure 1B), confirming
that the fractionation method enabled separation and
enrichment of hydrophobic proteins.
2-D PAGE/MS of M. agalactiae PG2T liposoluble proteins
Total proteins and the Triton X-114 soluble fraction of M.
agalactiae PG2T were subjected to 2-D PAGE separation
in order to evaluate the extent of enrichment in basic and
liposoluble proteins. As illustrated in Figure 2, left panel, a
very high number of spots were present in the total pro-
tein map of M. agalactiae PG2T but, as expected, basic
proteins were poorly represented. Upon comparison, the
2-D PAGE map generated with the Triton X-114 soluble
fraction showed a significant enrichment in basic proteins,
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with an excellent resolution also in high-abundance spots
(Figure 2, right panel).
In order to attain a systematic characterization of the
liposoluble proteome, the Triton X-114 phase fraction
of M. agalactiae PG2T was subjected to 2-D PAGE
under three different pI intervals: 3-10NL, 7-11, and 4-7
(Additional files 1, 2, and 3). From these 2D maps,
about 300 spots were excised and identified by MALDI-
TOF and nanoHPLC-nanoESI-Q-TOF MS. This
approach led to the successful identification of 40
unique proteins, corresponding to 5.4% of all M. agalac-
tiae PG2T genes. Figure 3 reports a representative lipo-
soluble protein map summarizing the main protein
identifications accomplished on 2-D spots. A detailed
description of all protein identifications is given in Addi-
tional file 4. Experimentally deduced molecular weight
and pI of protein spots were compared with the theore-
tical parameters obtained from MASCOT, and most
experimental data were in accordance with theoretical
data. Few proteins, such as VpmA, were detected in
multiple spots at different pIs and molecular weights, as
expected for this class of lipoproteins which undergo
size variation. The well-known immunogenic proteins
[12,17,19-21] were all detected by 2-D PAGE at the
expected pI and MW. All six variable surface lipopro-
teins encoded in the M. agalactiae PG2T genome were
also detected, some of which (such as VpmaY and
VpmaD) with high expression levels, as could be
expected considering their relevance in providing varia-
bility to the mycoplasmal antigenic mosaic.
2D DIGE of liposoluble proteins among the type strain
and two field isolates of M. agalactiae
In order to assess the suitability of 2-D PAGE for com-
parison of the membrane protein composition, the lipo-
soluble protein profiles of M. agalactiae PG2T and two
field isolates were compared by 2D DIGE (Figure 4).
The images generated upon acquisition of the single
color channels enable to evaluate the liposoluble protein
Figure 1 Total protein patterns and Western immunoblotting
reactivity of M. agalactiae PG2T proteins. Panel A. Coomassie
blue staining. Panel B: Immunoblotting reactivity obtained with
antibodies against the P48 lipoprotein. From left to right: M:
molecular weight standards in kDa; T: total protein pattern; H:
hydrosoluble protein fraction; L: liposoluble protein fraction
obtained after Triton X-114 fractionation.
Figure 2 2-D PAGE patterns of M. agalactiae PG2T protein extracts. Left: 2-D PAGE of a M. agalactiae PG2T total protein extract. Right: 2-D
PAGE of M. agalactiae PG2T liposoluble proteins obtained after Triton X-114 fractionation.
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profiles separately (Figure 4, A, B, C), while comparison
of two protein profiles can be performed upon superim-
position of two color signals (Figure 4, D, E, F). In the
overlay image, the three proteome 2D maps can be
compared. Although many spots are shared among the
three profiles (in white), a number of differences in
expression can be appreciated. In fact, several spots are
present only in one (blue, green, red) or two profiles
(purple, yellow, light blue). Many already known anti-
gens (such as P80, P48, P40, and most Vpmas) appear
in white, indicating superimposition of the three signals
and therefore presence in all three bacterial proteomes.
Several differences among the three profiles can be
easily observed; for example, the series of spots at 40
kDa corresponding to VpmaY (in purple in the overlay
image, Figure 4) is present only in two cases (PG2T and
Bortigali) while the series of spots at 23 kDa (in green)
is present only in one case (Nurri). The application of
this method to an adequate number of isolates might
enable to easily detect constantly expressed proteins
that might serve as candidate antigens for development
of vaccines and diagnostic tools.
GeLC-MS/MS of M. agalactiae PG2 liposoluble proteins
Although well suited for lipoprotein analysis, the 2-D
PAGE/MS strategy presents drawbacks in analysis of
transmembrane proteins, such as permeases or other
highly hydrophobic proteins. Moreover, these protein
classes may undergo selective loss during precipitation/
resolubilization steps. In order to increase the mem-
brane protein coverage and minimize selective protein
loss, SDS-PAGE and GeLC-MS/MS analysis were per-
formed on the non-precipitated Triton X-114 liposolu-
ble protein fraction. A total of 36 slices were cut from
the SDS-PAGE gel lane containing the separated liposo-
luble proteins (Additional file 5) and subjected to
nanoHPLC-nanoESI-Q-TOF-MS/MS identification.
Upon application of this method, 194 mycoplasma pro-
teins were identified in total, corresponding to 26% of
all M. agalactiae PG2T genes, 38 of which were also
Figure 3 2-D PAGE map of M. agalactiae PG2T liposoluble proteins illustrating protein identifications obtained by mass spectrometry.
Proteins are indicated by grouping all individual identifications corresponding to the same protein in a series of spots.
Cacciotto et al. BMC Microbiology 2010, 10:225
http://www.biomedcentral.com/1471-2180/10/225
Page 4 of 12
identified by 2-D PAGE/MS (for a detailed list of pro-
tein identifications, see Additional file 6; Additional file
7 reports a summary table listing all unique protein
identifications).
Data analysis and classification
A gene ontology (GO) classification was carried out on
proteins identified by 2-D PAGE/MS and GeLC-MS/
MS. For the first method, proteins (n = 40) were mostly
classified by the GO software as hypothetical lipopro-
teins (65%), cytoplasmic proteins (22%), ribosomal pro-
teins (8%), and other membrane-located proteins (5%).
When identifications obtained by GeLC-MS/MS were
also included in the GO analysis (n = 194), 43% of all
identifications were assigned to proteins located on the
membrane, either lipoproteins (17%) or other membrane
proteins (26%), whereas 36% were classified as cytoplas-
mic, 17% as ribosomal, and 4% of unknown localization
(Figure 5).
All protein identifications were then classified according
to function (Figure 6, and Additional file 7). As expected,
a high proportion of the identified proteins perform mem-
brane transport functions (about 16%), and belong mostly
to ABC transporters (13%). Transmembrane proteins,
Figure 4 2D DIGE of liposoluble proteins extracted from M. agalactiae PG2T and two field strains. Overlay image: image generated from
the superimposition of the signals generated by the three samples. White indicates presence of the protein spot in all three isolates. Panels A, B,
and C represent isolates PG2T, Nurri, and Bortigali, respectively. Panels D, E, and F represent the superimposition of Nurri/Bortigali, PG2T/Nurri,
and PG2T/Bortigali, respectively.
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such as permeases, were detected only by means of GeLC-
MS/MS. Another highly represented functional process
was translation (19%), due to the elevated number of ribo-
somal proteins identified. Hydrolytic enzymes were also
significantly represented (6%), highlighting their crucial
role for survival of mycoplasmas. Several other functional
classes, such as enzymes involved in amino acid, carbohy-
drate, lipid, and nucleic acid metabolism, were significantly
represented in the M. agalactiae PG2T liposoluble protein
fraction. Secretion/export systems accounted for 4% of all
identified proteins; these components are in fact crucial
for maturation and release of secreted proteins, but also
Figure 5 GO graph of proteins identified by 2-D PAGE-MS and GeLC-MS/MS in the Triton X-114 fraction of M. agalactiae PG2T. Protein
identifications are classified according to cellular localization.
Figure 6 GO graph of proteins identified by GeLC-MS/MS in the Triton X-114 fraction of M. agalactiae PG2T. Protein identifications are
classified according to function.
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for positioning/exposing lipoproteins on the outer side of
the bacterial cell. About 19% of proteins could not be
assigned a specific function by manual searches or GO
classification.
Proteomic data were analyzed in order to investigate
presence of liposoluble proteins resulting from expres-
sion of horizontally-transferred genes [24]. Among 194
identified proteins, 15 (7.8%) were acquired by HGT
from the Mycoplasma mycoides cluster (Additional file
8), while 7 (3.7%) were acquired by HGT from other
bacteria (Additional file 9), for a total of 22 proteins,
making up to 11.5% of all expressed membrane proteins
being derived from putative HGT events.
Discussion
Gathering proteomic information on prokaryotic mem-
branes is a challenging task, due to difficulties in cell
fractionation and to the intrinsic chemical properties
of membrane proteins in general. Therefore, both sys-
tematic and differential proteomic information on pro-
karyotic membranes is generally lacking. In this work,
we approached the systematic characterization of what
is believed to be one of the simplest bacterial pathogen
membranes, in an attempt to move a step forward in
our understanding of its composition, complexity, and
function. In addition to its lower complexity, investi-
gating membrane composition and plasticity in myco-
plasmas is of particular interest since surface proteins
are subjected to size and phase variation, and informa-
tion on the extent and level of such variation is crucial
in studies targeting identification of common immuno-
gens, evaluation of immunological escape mechanisms,
and adaptation of the bacterium to its host. All six
variable surface lipoproteins encoded in the PG2T gen-
ome [37] were detected by 2-D PAGE, although one of
these (VpmaY) was not expressed in a field isolate
examined by 2D DIGE. Triplicate experiments showed
that the two-dimensional expression pattern of each
field isolate is relatively stable under laboratory condi-
tions, and that there is a reproducible differential
expression of several protein spots in the field isolates
compared to the type strain PG2. Interestingly, these
differences are being detected in bacteria which were
grown in culture media, where all protein variants
should theoretically be expressed [37]. It was already
demonstrated that the switching mechanism is so fast
that it can be pointed out in a single colony on solid
culture [14]. This might suggest that the lack of
VpmaY in the isolate Nurri could result from a local
genetic mutation. A large-scale study performed on a
higher number of field isolates might enable the detec-
tion of constantly expressed proteins, which might be
useful as targets for the development of vaccines and
diagnostic tools for CA.
Mycoplasmas have evolved a parasitic lifestyle, and
membrane transporters are consequently very important
for uptake of nutrients and growth factors. The genome
of M. agalactiae PG2T encodes 18 ABC transporters,
but proteins from only 10 of these were identified in
this study. We also failed to identify all the components
of a complete membrane transporter complex; however,
it is possible that expression of all sequences encoded
by the transporter gene operon may not necessarily take
place at the same time. ABC transporters components
encoded by different operons may likely interact to form
functional transporters, producing the further advantage
of creating many different combinations that can help
evasion of host defense mechanisms. For instance, the
genome of M. agalactiae PG2T encodes for two oligo-
peptide (Opp) ABC transporters, one typical of the
hominis group and one probably transferred by means
of horizontal gene transfer mechanisms from M.
mycoides subsp. mycoides and M. capricolum subsp.
capricolum. We identified the substrate binding protein
(OppA) from one operon, and the permease (OppC)
and the ATP-binding protein (OppF) from another
operon; notably, these proteins create a functional trans-
porter. Moreover, OppA could be more than a simple
substrate binding protein, since it was demonstrated to
play an important role in pathogenicity in M. hominis
by inducing ATP release and cell death of HeLa cells in
vitro and by mediating adhesion to host cells [38-40].
Other authors reported a different pattern of expression
of these operons: in the study by Nouvel and co-workers
[37], only OppA, OppF, and OppD were detected. These
apparently controversial results could be due to techni-
cal issues, or be dependent on variations in expression
of Opps within the PG2T strain. This will need to be
elucidated in future studies.
Upon analysis of all MS data, the proteins putatively
assigned by the GO software as cytoplasmic accounted
to 36%. Among these, many hydrolases were present.
However, lipases, peptidases, and nucleases might be
associated to the membrane compartment and assist in
reducing macromolecules to simple components,
enabling their uptake. In fact, mycoplasmas lack many
biosynthetic pathways and rely on internalization of
nucleotides, amino acids, sugars and lipids from their
external environment. Recently, it was reported that
hydrolytic enzymes are surface-located in mycoplasmas,
and that they can be associated with ABC transporters
in order to digest macromolecules before uptake of sim-
pler components, or play major roles in pathogenicity
[41]. Interestingly, in the M. agalactiae genome, the
genes coding for many of these hydrolases are also
located close to ABC transporter operons.
Several other proteins have a predicted cytoplasmic
localization, but could be membrane-associated in
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mycoplasmas, such as the elongation factor tu (EF-Tu)
and the E1 beta subunit of the pyruvate dehydrogenase
complex. Traditionally, these are considered to be cyto-
plasmic proteins involved in protein synthesis and
energy production, respectively, but it was demonstrated
that in M. pneumoniae they are surface exposed and
interact with host fibronectin, mediating adhesion
[42,43]. It was also demonstrated that many “cytoplas-
mic” proteins such as the EF-Tu are strong antigens in
many mycoplasma species [22,44,45].
Ribosomal proteins represent a significant proportion
of the mycoplasma liposoluble proteome. This might
appear inconsistent, but in spite of their traditionally
cytoplasmic localization, it was already demonstrated
that ribosomes interact with the bacterial protein export
complex [46]. Moreover, it is well known that in eukar-
yotes ribosomes are associated with endoplasmic reticu-
lum, where they participate in the protein secretion
pathway [47]. Several proteins that take part in other
metabolic pathways were also identified in the liposolu-
ble fraction of M. agalactiae PG2T. We could speculate
that many proteins involved in nutrient metabolism
might associate with proteins devoted to internalization
of precursors in metabolizing complexes, and be co-pur-
ified with these. Nonetheless, a pre-fractionation of
membranes was not performed because of inherent
technical difficulties, and we cannot rule out that
enzymes with high hydrophobicity might be present as
cytoplasmic contaminants.
The recent work by Sirand-Pugnet and coworkers
revealed the occurrence of horizontal gene transfer
(HGT) events in M. agalactiae. The expression of pro-
teins acquired by HGT highlights the importance of
horizontal gene flow for the evolutionary plasticity of
mycoplasmas; for instance, by allowing changes in host
and/or tissue tropism through acquisition of traits
enabling colonization and survival in new niches [24,48].
In total, an impressing 11.7% of proteins expressed on
the M. agalactiae membrane are coming from other
bacteria, reinforcing the view that an important part in
the evolution of mycoplasmas might be driven by
genetic exchange with bacteria sharing the same host
districts, probably in order to compensate the concur-
rent process of gene loss [24]. Another interesting
observation was the detection of MAG_2340, a hypothe-
tical lipoprotein which is apparently the result of an
horizontal gene transfer event with mycoplasmas of the
mycoides cluster (Additional file 8), which was not
detected by Nouvel et al. in the PG2T liposoluble pro-
teome [37].
Hypothetical proteins were of particular interest; since
these did not have an assigned function, similarity
searches were conducted with BLAST tools in order to
infer their possible role in the biology of mycoplasmas.
Among these, the hypothetical lipoprotein MAG_1670
belongs to the mycoides cluster LppA/P72 family, and it
is an antigen recognized early and persistently in infec-
tion [49]. The hypothetical protein MAG_0250 has an
indigoidine synthase A (IdgA)-like domain similar to
Clostridium spp. IdgA is involved in the biosynthesis of
indigoidine, a blue pigment synthesized by Erwinia chry-
santhemi and implicated in pathogenicity and protection
from oxidative stress by scavenging oxygen radicals [50].
Indigoidine production increases tolerance to oxidative
stress and contributes to aggressiveness, and might
therefore act as a virulence factor.
Conclusions
2-D PAGE studies might be extremely powerful for
comparison of protein expression in different myco-
plasma isolates, especially when considering that lipo-
proteins can be selectively detected with this method,
and that size and phase variations can be easily spotted
through the application of powerful differential compari-
son approaches as the 2D DIGE. However, these need to
be integrated with traditional Western immunoblotting
and GeLC-MS/MS for a deeper coverage and characteri-
zation of other mycoplasmal surface immunogens to be
used as tools for vaccination, diagnosis, and therapy.
This combined approach allowed the identification and
characterization of 194 M. agalactiae proteins putatively
localized on the membrane or associated to it, providing
useful insights on its composition. In the future, alterna-
tive approaches such as blue native electrophoresis and
chemical crosslinking of surface proteins will also enable
to elucidate functional and structural aspects of mem-
brane proteins that cannot be accounted for by the tra-
ditional gel-based proteomic approaches.
Methods
Bacterial strains and culture conditions
At least three replicate cultures of Mycoplasma agalactiae
PG2T and two Sardinian field isolates (named Bortigali
and Nurri), were grown in PPLO medium supplemented
with 20% heat inactivated horse serum and 500 μg/mL
ampicillin, at 37°C with constant agitation. Mycoplasmas
were collected by centrifugation (10 min at 10,000 × g at
4°C), and washed three times with PBS. At least three
mycoplasma pellets were obtained from each bacterial
culture replicate, and used for genetic and proteomic ana-
lyses. Total DNA was extracted from a set of pellets with
DNeasy Blood & Tissue Kit (Qiagen), and subjected to
FS1-FS2 PCR for species confirmation [51].
Total protein extracts and Triton X-114 fractionation
For total protein extracts, bacterial pellets were resus-
pended in 1% hot SDS, incubated for 3 minutes at 95°C,
chilled, and diluted with lysis buffer (7 M urea, 2 M
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thiourea, 2.5% CHAPS, 2% ASB-14, 40 mM Tris-HCl
pH 8.8, 1% IPG-buffer, protease inhibitors), and insolu-
ble materials were discarded by centrifugation (10 min
at 10,000 × g at 4°C) [52]. Hydrophilic and hydrophobic
protein fractions were obtained by Triton X-114 fractio-
nation [29,30] and ProteoPrep® Membrane Extraction
Kit (Sigma-Aldrich). Proteins samples were quantified as
described [52].
SDS-PAGE and 2-D PAGE
SDS-PAGE was performed on 8% polyacrylamide gels
on a Protean Tetra Cell (Bio-Rad) following the manu-
facturer instructions, and gels were stained with Page-
Blue™ Protein Staining Solution (Fermentas).
Prior to 2-D PAGE, Triton X-114 fractions were pre-
cipitated with methanol-chloroform [35] and resus-
pended in lysis buffer (8 M urea, 2 M thiourea, 2.5%
CHAPS, 2% ASB-14, 40 mM Tris-HCl pH 8.8, 1% IPG-
buffer, protease inhibitors). Resuspended proteins (150
μg) were then absorbed overnight into 18 cm IPG strips
(GE Healthcare, pH 3-10 NL, pH 7-11, and pH 4-7).
Strips were focused on an IPGphor (GE Healthcare) for
a total of 60,000 Vh. After focusing, strips were equili-
brated in 50 mM Tris-HCl, pH 6.8, 2% SDS, 7 M urea,
10% glycerol, supplemented with 2% DTT for 15 min,
and then with 2.5% iodoacetamide for 15 min. The sec-
ond dimension (SDS-PAGE) was conducted on 10% to
18% polyacrylamide gradient gels, on an Ettan DALTsix
electrophoresis system (GE Healthcare), following man-
ufacturer’s instructions. 2-D gels were silver stained with
a mass-compatible method [53] and images were digita-
lized with an Image Scanner (GE Healthcare).
2D DIGE
For 2D DIGE analysis, the two field isolates Bortigali
and Nurri were compared to PG2T. Triton X-114 Pro-
tein extracts were precipitated and resuspended in lysis
buffer as described above. Then, samples were labeled
with CyDye DIGE Fluors (GE Healthcare) according to
the minimal labeling protocol provided by the manufac-
turer. Briefly, after CyDye reconstitution with dimethyl-
formamide (DMF) and preparation of a working
solution (200 pmol/μL), 1 μL of diluted CyDye was
added to a volume of protein sample equivalent to 50
μg. Samples were left on ice for 30 minutes in the dark,
and then 1 μL of 10 mM lysine was added to stop the
reaction. Labeled samples were mixed, IPG buffer corre-
sponding to the desired pH range was added at a 1%
final concentration, and DeStreak Rehydration Solution
(GE Healthcare) was added to a total volume of 340 μL.
18 cm IPG strips (GE Healthcare) were passively rehy-
drated for at least 6 hours. IEF was carried out on an
Ettan IPGphor II (GE Healthcare) for a total of ~60,000
Vh. After focusing, strips were equilibrated in 50 mM
Tris-HCl, pH 6.8, 2% SDS, 7 M urea, 10% glycerol, sup-
plemented with 2% DTT for 10 min, and then with
2.5% iodoacetamide for 10 min. Proteins were then sub-
jected to SDS-PAGE in 10-18% gradient polyacrylamide
gels on the Ettan DALTsix system (GE Healthcare), fol-
lowing the manufacturer instructions. DIGE images
were detected with a Typhoon Scanner (GE Healthcare)
and processed with DeCyder (GE Healthcare) for image
analysis.
Western Immunoblotting
SDS-PAGE resolved proteins were transferred onto
nitrocellulose membranes with a Mini-Trans-Blot Cell
(Bio-Rad) at 250 mA for one hour. After blotting, mem-
branes were blocked with PBS-0.05% Tween 20 (PBS-T)
containing 3% BSA. Membranes were incubated for one
hour with a rabbit hyperimmune serum raised against M.
agalactiae recombinant P48 (M. agalactiae rP48) [12].
Membranes were washed five times with PBS-T and
incubated with the appropriate HRP-conjugated second-
ary antibodies (Sigma). After five washes, membranes
were developed with SuperSignal West Pico Chemilumi-
nescent Substrate (Pierce) and images were acquired with
a VersaDoc MP 4000 Imaging System (Bio-Rad).
Spot picking and in situ tryptic digestion
Protein spots obtained upon 2-D PAGE separation of
the Triton X-114 extract from the strain PG2T were
manually excised from gels, destained with 15 mM K3Fe
(CN)6 in 50 mM Na2S2O3 and stored in acetonitrile.
Spots were then subjected to an O/N tryptic digestion
at 37°C in 50 mM (NH4)HCO3, pH 8.0, using 40 to
80 ng of trypsin depending on spot intensity. Peptide
mixtures were collected by elution with acetonitrile fol-
lowed by centrifugation. Peptides were then acidified
with TFA 20%, dried in SpeedVac®, resuspended in 0.2%
formic acid and stored at -20°C.
GeLC-MS/MS
The Triton X-114 fraction was diluted with 4× Laemmli
buffer [54], 20 μg of proteins were loaded in an 8%
polyacrylamide gel, and SDS-PAGE was performed as
previously described. After gel staining, bands were
manually excised, destained, reduced, alkylated, and
finally subjected to in situ tryptic digestion as previously
described [55]. Peptide mixtures were identified by
nanoHPLC-nanoESI-Q-TOF-analysis. One-dimensional
patterns were analyzed with Quantity One software
(Bio-Rad).
MALDI-MS
Mass spectra were recorded on a MALDI micro
(Waters, Manchester, UK) equipped with a reflectron
analyzer and used in delayed extraction mode, as
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described previously [56]. Peptide samples were mixed
with an equal volume of a-cyano-4-hydroxycynnamic
acid as matrix (10 mg/mL in acetonitrile/0.2% TFA)
(70:30, v/v), applied to the metallic sample plate, and
air dried. Mass calibration was performed by using the
standard mixture provided by manufacturer. Raw data,
reported as monoisotopic masses, were then
introduced into the in-house Mascot Peptide Mass
Fingerprinting software (Version 2.2, Matrix Science,
Boston, MA), and used for protein identification. Search
parameters were as follows: fixed modifications carba-
midomethyl (C), variable modifications pyro-Glu
(N-term Q) and oxidation (M), peptide tolerance 80
ppm, enzyme trypsin, allowing up to 2 missed cleavages.
LC-MS/MS
LC-MS/MS analyses of tryptic digests were performed on
a Q-TOF hybrid mass spectrometer equipped with a nano
lock Z-spray source, and coupled on-line with a capillary
chromatography system CapLC (Waters, Manchester,
UK), as described previously [55]. After loading, the pep-
tide mixture was first concentrated and washed at 20 μL/
min onto a reverse-phase pre-column (Symmetry 300,
C18, 5 μm, NanoEase, Waters) using 0.2% formic acid as
eluent. The sample was then fractionated onto a C18
reverse-phase capillary column (Nanoflow column 5 μm
Biosphere C18, 75 μm × 200 mm, Nanoseparations) at a
flow rate of 250 nL/min, using a linear gradient of eluent
B (0.2% formic acid in 95% acetonitrile) in A (0.2% formic
acid in 5% acetonitrile) from 2 to 40% in 27 min. The
mass spectrometer was set up in a data-dependent MS/
MS mode where a full scan spectrum (m/z acquisition
range from 400 to 1600 Da/e) was followed by tandem
mass spectra (m/z acquisition range from 100 to 2000 Da/
e). Peptide ions were selected as the three most intense
peaks of the previous scan. A suitable collision energy was
applied depending on the mass and charge of the precur-
sor ion. Argon was used as the collision gas. Mass calibra-
tion was conducted on the Glu-fibrino peptide B (Sigma)
fragmentation pattern. ProteinLynx software (Version
2.2.5), provided by the manufacturers, was used to analyze
raw MS and MS/MS spectra and to generate a peak list
which was introduced in the in-house Mascot MS/MS ion
search software (Version 2.2, Matrix Science, Boston, MA)
for protein identification. NCBI was used as sequence
database. Search parameters were as follows: fixed modifi-
cations carbamidomethyl (C), variable modifications pyro-
Glu (N-term Q) and oxidation (M), peptide tolerance 30
ppm, MS/MS tolerance 0.3 Da, charge state +2 and +3,
enzyme trypsin, allowing up to 1 missed cleavage.
Data analysis
MS data were subjected to gene ontology analysis with
Blast2GO, using default parameters [57]. Identified
proteins were divided into classes for functional and
localization analysis; data produced by the software were
used for generation of graphs by Microsoft Excel.
Additional material
Additional file 1: 2-D PAGE map of liposoluble proteins from M.
agalactiae PG2T illustrating the protein identifications obtained by
MS on the 3-10NL pI Interval.
Additional file 2: 2-D PAGE map of liposoluble proteins from M.
agalactiae PG2T illustrating the protein identifications obtained by
MS on the 7-11 pI Interval.
Additional file 3: 2-D PAGE map of liposoluble proteins from M.
agalactiae PG2T illustrating the protein identifications obtained by
MS on the 4-7 pI Interval.
Additional file 4: Table listing all protein identifications obtained
from 2-D PAGE maps. The proteins listed in this table were identified
from 2-D PAGE maps of the M. agalactiae PG2T Triton X-114 fraction.
Maps are represented in Additional files 1 (pH 3-10NL), 2 (pH 7-11) and 3
(pH 4-7).
Additional file 5: Protein profile of liposoluble proteins before and
after precipitation. Right: approach used for GeLC-MS/MS
characterization. The bars indicate the regions cut from the PAGE gel
and subjected to mass spectrometry characterization. Protein
identifications are reported in additional file 6, from top to bottom.
Additional file 6: Table listing all protein identifications obtained by
GeLC-MS/MS of the M. agalactiae PG2T Triton X-114 liposoluble
fraction. The protein profile used and the number of slices are reported
in Additional file 5.
Additional file 7: Functional analysis, number of peptide hits, and
method of detection of M. agalactiae PG2T liposoluble proteins. The
results of 2D DIGE with the two field strains Nurri and Bortigali are also
reported (TPH, total peptide hits; NA, not applicable).
Additional file 8: Proteins identified in the M. agalactiae proteome
potentially resulting from Horizontal Gene Transfer events with M.
mycoides subsp. mycoides and M. capricolum subsp. capricolum.
Additional file 9: Proteins identified in the M. agalactiae proteome
potentially resulting from Horizontal Gene Transfer events with
other bacteria.
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